News

A proposal that could bring £60million investment into the life sciences sector in Kent has taken a significant stride forward by securing £50,000 to develop the bid further. The money is seedcorn funding via UK Research and Innovation’s flagship £236m Strength in Places Fund.

Bearing the CE mark and IVD symbol signifies that the AccuPlex SARS-CoV-2 Molecular Controls Kit meets extensive design control requirements.

Proficiency testing (PT), often known as External Quality Assessment (EQA) in the clinical sector, allows laboratories to assess their measurement processes with test materials that we send them.

Expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining safety features

Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma.

The National Measurement Laboratory (NML), hosted at LGC, welcomes the publication of the UK government’s Research and Development (R&D) Roadmap with its ongoing commitment to increased investment in R&D to cement the UK’s world-leading position within science and research and support the individuals behind it.

Dr Jim Huggett, Principal Scientist at the NML at LGC, recently answered some of our questions around why standardised measurement is so important to medicine.

A leading expert in food safety and authenticity, and a longtime partner of IGFS, Michael Walker has received an honorary professorship from Queen’s University Belfast.

Will each contribute extensive experience and capabilities in small and large molecule bioanalysis to support customer-centric approach

Research programme brings together experts who are highly experienced in evaluating diagnostic tests and generating robust evidence required for a test to be used in the NHS

Dexamethasone has undergone study by a team of scientists at Oxford University as part of their Recovery trial.

Panel demonstrates a range of SARS-CoV-2 antibody reactivity